These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35628499)

  • 1. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
    Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial.
    Lee CJ; Modave E; Boeckx B; Stacchiotti S; Rutkowski P; Blay JY; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
    Schöffski P; Wozniak A; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Gelderblom H; Italiano A; Lindner LH; Hennig I; Strauss S; Zakotnik B; Anthoney A; Albiges L; Blay JY; Reichardt P; Sufliarsky J; van der Graaf WTA; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Raveloarivahy T; Collette S; Stacchiotti S
    Ann Oncol; 2018 Mar; 29(3):758-765. PubMed ID: 29216400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.
    Ju X; Sun K; Liu R; Li S; Abulajiang G; Zou H; Lan J; Ren Y; Jiang J; Liang W; Pang L; Li F
    Pathol Oncol Res; 2018 Jul; 24(3):593-600. PubMed ID: 28766250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
    Paoluzzi L; Maki RG
    JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs.
    Sicinska E; Kola VSR; Kerfoot JA; Taddei ML; Al-Ibraheemi A; Hsieh YH; Church AJ; Landesman-Bollag E; Landesman Y; Hemming ML
    Cancer Res; 2024 Jul; 84(14):2247-2264. PubMed ID: 38657118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.
    Kenney S; Vistica DT; Stockwin LH; Burkett S; Hollingshead MG; Borgel SD; Butcher DO; Schrump DS; Shoemaker RH
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):360-8. PubMed ID: 21552147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02).
    Xie L; Liang X; Xu J; Sun X; Liu K; Sun K; Li Y; Tang X; Li X; Zhan X; Niu X; Guo W
    BMC Cancer; 2023 Sep; 23(1):868. PubMed ID: 37715133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study.
    Mcaddy NC; Saffar H; Litière S; Jespers P; Schöffski P; Messiou C
    Cancer Imaging; 2020 Oct; 20(1):79. PubMed ID: 33121537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
    Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
    Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
    Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
    Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
    Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
    Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
    Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
    Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
    Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
    Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
    Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary alveolar soft part sarcoma of the rectum resected by endoscopic submucosal dissection: A case report.
    Nakayama A; Yokota A; Suzuki Y; Iizuka T; Fukawa T; Ushiku T; Takazawa Y; Fujii T
    Pathol Int; 2020 Aug; 70(8):581-586. PubMed ID: 32515162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lingual Alveolar Soft Part Sarcoma in a 78-Year-Old Woman: A Case Report and Comprehensive Review of the Literature from 1952 to 2022.
    Aksionau A; Dela Cruz NE; Meram AT; Cuellar-Saenz H; Aveni JR; Takei H
    Head Neck Pathol; 2023 Mar; 17(1):265-274. PubMed ID: 36303014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.